o-desmethylangolensin has been researched along with Body Weight in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atkinson, C; Frankenfeld, CL; Lampe, JW; Wähälä, K | 1 |
| Fujii, S; Fujioka, M; Ishimi, Y; Katsumata, S; Takeda, K; Uehara, M | 1 |
2 other study(ies) available for o-desmethylangolensin and Body Weight
| Article | Year |
|---|---|
Obesity prevalence in relation to gut microbial environments capable of producing equol or O-desmethylangolensin from the isoflavone daidzein.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Body Mass Index; Body Weight; Cross-Sectional Studies; Equol; Female; Gastrointestinal Tract; Humans; Isoflavones; Male; Microbiota; Middle Aged; Obesity; Overweight; Phenotype; Prevalence; Self Report; Soy Foods; Young Adult | 2014 |
Kanamycin inhibits daidzein metabolism and abilities of the metabolites to prevent bone loss in ovariectomized mice.
Topics: Administration, Oral; Animals; Biotransformation; Body Weight; Bone Density; Diet; Disease Models, Animal; Equol; Female; Femur; Humans; Isoflavones; Kanamycin; Mice; Organ Size; Osteoporosis; Ovariectomy; Phytoestrogens; Uterus | 2016 |